Jörg Breitkreutz studied Pharmacy from 1987 to 1991 at the Westphalian Wilhelms-University of Münster, Germany. He finished his PhD in 1996 at the Institute for Pharmaceutical Technology and Biopharmaceutics in Münster under the supervision of Prof. Rüdiger Gröning. From 1996 to 1997 he joined Thiemann Arzneimittel GmbH in Waltrop, Germany, as the Head of Product Coordination. In 1997 he went back to the university in Münster to work on his habilitation thesis (2004) on pediatric drug formulations. In 2004 he became professor for pharmaceutical technology at the Institute of Pharmaceutics and Biopharmaceutics at the Heinrich-Heine-University in Düsseldorf, Germany and today is the director of this institute. Joerg Breitkreutz is member of the European Paediatric Formulation Initiative (EuPFI) and serves as external expert for various regulatory bodies and companies. In 2010 the non-for-profit International Association of Pharmaceutical Technology (APV) elected him for the president. His research focuses on pediatric and geriatric drug formulations, development of orphan drugs and process analytical technologies.